The PE Ratio as of September 2024 (TTM) for argenx SE (ARGX) is -155.75

According to argenx SE’s latest financial reports and current stock price. The company's current PE Ratio is -155.75. This represents a change of 38.96% compared to the average of -112.08 of the last 4 quarters.

argenx SE (ARGX) Historical PE Ratio (quarterly & annually)

How has ARGX PE Ratio performed in the past?

The mean historical PE Ratio of argenx SE over the last ten years is -32.16. The current -155.75 PE Ratio has changed 48.33% with respect to the historical average. Over the past ten years (40 quarters), ARGX's PE Ratio was at its highest in in the March 2019 quarter at 157.16. The PE Ratio was at its lowest in in the June 2018 quarter at -460.15.

argenx SE (ARGX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of argenx SE PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

argenx SE (ARGX) Average PE Ratio

How has ARGX PE Ratio performed in the past?

The current PE Ratio of argenx SE (ARGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

argenx SE (ARGX) PE Ratio vs. Peers

How is ARGX’s PE Ratio compared to its peers?

argenx SE’s PE Ratio is less than IVERIC bio, Inc. (-33.43), less than Blueprint Medicines Corporation (-26.44), less than Amylyx Pharmaceuticals, Inc. (-0.97), less than Karuna Therapeutics, Inc. (-29.52), less than Day One Biopharmaceuticals, Inc. (-7.39), less than Mirati Therapeutics, Inc. (-5.32), less than Terns Pharmaceuticals, Inc. (-6.06), less than Apellis Pharmaceuticals, Inc. (-15.28), less than Legend Biotech Corporation (-30.94), less than Zai Lab Limited (-6.49), less than Seagen Inc. (-57.36), greater than Alnylam Pharmaceuticals, Inc. (-428.77), less than Ascendis Pharma A/S (-12.57), less than Vaxcyte, Inc. (-26.31), less than Travere Therapeutics, Inc. (-5.83), less than Akero Therapeutics, Inc. (-8.95), less than BeiGene, Ltd. (-38.25),

Build a custom stock screener for argenx SE (ARGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like argenx SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

argenx SE (ARGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like argenx SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.